Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01GNL
|
|||
| Drug Name |
Pyrazolopyridine derivative 5
|
|||
| Synonyms |
PMID27774822-Compound-Figure9Example1topleft
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
TAKEDA PHARMACEUTICAL COMPANY LIMITED
|
|||
| Structure |
 |
Download2D MOL |
||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | TYK2 tyrosine kinase (TYK2) | Target Info | Inhibitor | [1] |
| Target's Patent Info | TYK2 tyrosine kinase (TYK2) | Target's Patent Info | [1] | |
| KEGG Pathway | Osteoclast differentiation | |||
| Jak-STAT signaling pathway | ||||
| Toxoplasmosis | ||||
| Hepatitis C | ||||
| Measles | ||||
| Influenza A | ||||
| Herpes simplex infection | ||||
| Epstein-Barr virus infection | ||||
| Pathway Interaction Database | IL27-mediated signaling events | |||
| Signaling events mediated by PTP1B | ||||
| IL12-mediated signaling events | ||||
| IL6-mediated signaling events | ||||
| IL23-mediated signaling events | ||||
| Reactome | Interleukin-6 signaling | |||
| MAPK3 (ERK1) activation | ||||
| MAPK1 (ERK2) activation | ||||
| Interferon alpha/beta signaling | ||||
| Regulation of IFNA signaling | ||||
| WikiPathways | Interferon type I signaling pathways | |||
| IL-4 Signaling Pathway | ||||
| IL-6 signaling pathway | ||||
| Oncostatin M Signaling Pathway | ||||
| Interleukin-11 Signaling Pathway | ||||
| Type III interferon signaling | ||||
| Interferon alpha/beta signaling | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Inhibitors of JAK-family kinases: an update on the patent literature 2013-2015, part 2.Expert Opin Ther Pat. 2017 Feb;27(2):145-161. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.